Christi Shaw

Christi Shaw is a declared insider at 3 companies (board member); the most frequent names are ELI LILLY & Co, Avantor, Inc. and Kyverna Therapeutics, Inc. We count 19 filings; the first trade dates from 1 May 2018 and the latest from 12 January 2026.

Sales make up the whole of the open-market record (6 sales, €3.0M). Other entries cover 11 share grants and 2 option exercises.

The newest entry dates from 14 January 2026: a share grant, in Kyverna Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.